The Potential of MicroRNAs as Clinical Biomarkers to Aid Ovarian Cancer Diagnosis and Treatment

Ovarian cancer is a commonly diagnosed malignancy in women. When diagnosed at an early stage, survival outcomes are favourable for the vast majority, with up to 90% of ovarian cancer patients being free of disease at 5 years follow-up. Unfortunately, ovarian cancer is typically diagnosed at an advan...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Molly, Davey, Matthew G., Miller, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690044/
https://www.ncbi.nlm.nih.gov/pubmed/36360295
http://dx.doi.org/10.3390/genes13112054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690044/
https://www.ncbi.nlm.nih.gov/pubmed/36360295
http://dx.doi.org/10.3390/genes13112054

Ejemplares similares